Ocean acidification along the 24.5°N section in the subtropical North Atlantic

9 páginas, 4 figuras.-- Proyecto CarbochangeOcean acidification is directly related to increasing atmospheric CO2 levels due to human activities and the active role of the global ocean in absorbing part of this anthropogenic CO2. Here we present an assessment of the pH changes that have occurred along 24.5°N in the subtropical North Atlantic through comparison of pH observations conducted in 1992 and 2011. It reveals an overall decline in pH values in the first 1000 dbar of the water column. The deconvolution of the temporal pH differences into anthropogenic and nonanthropogenic components reveals that natural variability, mostly owed to a decrease in oxygen levels in particular regions of the section, explains the vertical distribution of the larger pH decreases (up to −0.05 pH units), which are found within the permanent thermocline. The detection of long-term trends in dissolved oxygen in the studied region gains importance for future pH projections, as these changes modulate the anthropogenically derived acidification. The anthropogenic forcing explains significant acidification deeper than 1000 dbar in the western basin, within the Deep Western Boundary Current.We acknowledge funding from the Spanish Ministry of Economy and Competitiveness through grants CSD2008-00077 (Circumnavigation Expedition MALASPINA 2010 Project), CTM2009-08849 (ACDC Project), and CTM2012-32017 (MANIFEST Project) and from the Seventh Framework Programme FP7 CARBOCHANGE (grant agreement 264879). E.F. Guallart was funded by CSIC through a JAE-Pre grant.Peer reviewe

Air-sea CO2 fluxes in the Atlantic as measured during the FICARAM cruises

A total of fourteen hydrographic cruises spanning from 2000 to 2008 were conducted during the spring and autumn seasons between Spain and the Southern Ocean, under the framework of the Spanish research project FICARAM. The performed underway measurements are processed and analysed to describe the meridional air-sea CO2 fluxes (F CO2) along the Atlantic Ocean. The data was organised into different biogeochemical oceanographic provinces, according mainly to the thermohaline characteristics. The obtained spatial and temporal distributions of F CO2 follow the generally expected patterns and annual trends. The Subtropical regions in both hemispheres alternated the CO2 source and sink nature from autumn to spring, respectively. On the other hand, Tropical waters and the Patagonian Sea clearly behaved as sinks of atmospheric CO2 like the waters of the Drake Passage during autumn. The obtained results during the cruises also revealed significant long-term trends, such as the warming of equatorial waters (0.11±0.03 Cyr−1) and the decrease of surface salinity (−0.16±0.01 yr−1) in tropical waters caused by the influence of the Amazon River plume. This reduction in surface salinity appears to have a direct influence over the CO2 storage rates, fostering the uptake capacity of atmospheric CO2 (−0.09±0.03 molm−2 yr−1). An analysis of the biogeochemical forcing on the CO2 fugacity (fCO2) variability performed from an empirical algorithm highlighted the major role of the Amazon River input in the tropical North Atlantic fluxes. In addition, it has provided a quantitative measure of the importance of the thermodynamic control of F CO2 at temperate latitudes

Tuning intermolecular charge transfer in donor-acceptor two-dimensional crystals on metal surfaces

Organic charge transfer (CT) compounds display a wide range of exotic electronic properties (charge-density wave stabilization, Peierls transitions, etc.) depending on the amount of charge transferred from the donor (D) to the acceptor (A) species. A complete exploration of the complex electronic phase diagrams for such compounds would thus require methods to systematically tune the amount of charge exchanged in the CT process. This has proven however challenging in the past: chemical functionalization of the constituent molecules can also affect the packing of the molecular units in the crystal, whereas changing D:A stoichiometry is often not possible in the bulk. Interestingly, it was recently found that multiple stoichiometries can actually be achieved by codeposition of different amounts of D and A molecules on metal surfaces. The question, however, of whether CT processes between D and A molecules can be tuned with the D:A ratio in such mixtures has not yet been studied, and it is no trivial matter, since competing CT processes between the metal surface and the organic adsorbates might hinder interadsorbate charge transfer. Here we demonstrate that the CT process from the organic donor tetrathiafulvalene (TTF) to the acceptor tetracyanoquino-p-dimethane (TCNQ) can be tuned with exquisite accuracy (∼0.1 e) by controlling the stoichiometry of D:A cocrystals deposited on Ag(111). This control opens new avenues to explore the complex phase diagrams of organic CT compounds and to tailor their electronic properties.The authors acknowledge financial support from the Spanish Ministry for Economy and Competitiveness (Grants FIS2012-33011, FIS2015-67367-C2-1-P, FIS2013-42002-R, FIS2016-77889-R, CTQ2013-43698-P, CTQ2016-76061-P), the regional government of Comunidad de Madrid (Grants S2009/MAT1726 and S2013/MIT-3007), Universidad Autónoma de Madrid (UAM/48) and IMDEA Nanoscience. L.F. acknowledges financial support from MIUR (PRIN-2010BNZ3F2, Project DESCARTES), S.D.-T. acknowledges the ‘“Ramón y Cajal”’ program of the MINECO (RYC-2010-07019), and the María de Maeztu Programme for Units of Excellence in R&D of the MINECO (MDM-2014-0377)

Metabolic syndrome and urinary acid stones

Introducción: Estudios epidemiológicos han puesto de manifiesto la asociación de urolitiasis con una serie de enfermedades de reconocido riesgo cardiovascular como la diabetes mellitus tipo 2, hipertensión arterial y síndrome metabólico. Es nuestro objetivo determinar la frecuencia del síndrome metabólico en una serie de pacientes diagnosticados en nuestro Servicio de cálculos de ácido úrico. Material y métodos: Se incluye un total de 71 pacientes diagnosticados de litiasis de ácido úrico, 46 varones y 25 mujeres, con una edad media de 62,4 años. La lateralidad y localización del cálculo se confirma por ecografía y/o tomografía axial computerizada. Se establece el diagnóstico del síndrome metabólico siguiendo los criterios propuestos por el NCEP-ATP III. Se realiza análisis estadístico con test de chi-cuadrado aplicando corrección de Yates. Resultados: Se observó síndrome metabólico en 49 pacientes (69,0%), muy por encima del 31% de la frecuencia reportada para la población española (p<0.0001). Además se comprobó descenso de HDL-colesterol sérico en 59 pacientes (83,1%), obesidad abdominal en 48 (67,8%), hipertensión arterial en 46 (64,8%), hipertrigliceremia en 39 (54,9%) e hiperglucemia en 31 (43,7%), mostrando todos estos factores diferencias estadísticamente significativas en relación con los datos registrados para la población general española. Conclusiones: Existe una marcada relación entre litiasis de ácido úrico y síndrome metabólico, como también para cada uno de los factores que constituyen el síndrome metabólico, con porcentajes que están muy por encima de su frecuencia poblacional registrada en España.Introduction: Epidemiologic studies have reported association between urolithiasis with cardiovascular diseases as type 2 diabetes, arterial hypertension and metabolic syndrome. This study was conducted to examine the proportion of metabolic syndrome in patients with uric acid stones. Materials and methods: 71 patients with uric acid stones were included, 46 males and 25 females, mean age was 62.4 years. Diagnosis of stone laterality and localization was confirmed by ultrasonography and/or computerized axial tomography. Metabolic syndrome definition was made according of criteria proposed by NCEP-ATP III. Chisquare test with correction of Yates was used to assess the statistical significance of differences. Results: Metabolic syndrome were observed in 49 patients (69.0%), significantly higher than 31% rate reported for Spanish population (p<0.0001). In addition, it was found decrease serum HDL-cholesterol in 59 patients (83.1%), abdominal obesity in 48 (67.8%), high blood pressure in 46 (64.8%), hypertrigliceremia in 39 (54.9%) and hyperglycemia in 31 (43.7%), all of that was significantly more frequent than data reported for Spanish population. Conclusions: Uric acid stones were positively associated with metabolic syndrome, as well as for each of the factors of metabolic syndrome, with rates higher than registered in Spanish population

Neuroprotective Natural Molecules, From Food to Brain

The prevalence of neurodegenerative disorders is increasing; however, an effective neuroprotective treatment is still remaining. Nutrition plays an important role in neuroprotection as recently shown by epidemiological and biochemical studies which identified food components as promising therapeutic agents. Neuroprotection includes mechanisms such as activation of specific receptors, changes in enzymatic neuronal activity, and synthesis and secretion of different bioactive molecules. All these mechanisms are focused on preventing neuronal damage and alleviating the consequences of massive cell loss. Some neuropathological disorders selectively affect to particular neuronal populations, thus is important to know their neurochemical and anatomical properties in order to design effective therapies. Although the design of such treatments would be specific to neuronal groups sensible to damage, the effect would have an impact in the whole nervous system. The difficult overcoming of the blood brain barrier has hampered the development of efficient therapies for prevention or protection. This structure is a physical, enzymatic, and influx barrier that efficiently protects the brain from exogenous molecules. Therefore, the development of new strategies, like nanocarriers, that help to promote the access of neuroprotective molecules to the brain, is needed for providing more effective therapies for the disorders of the central nervous system (CNS). In order both to trace the success of these nanoplatforms on the release of the bioactive cargo in the CNS and determinate the concentration at trace levels of targets biomolecules by analytical chemistry and concretely separation instrumental techniques, constitute an essential tool. Currently, these techniques are used for the determination and identification of natural neuroprotective molecules in complex matrixes at different concentration levels. Separation techniques such as chromatography and capillary electrophoresis (CE), using optical and/or mass spectrometry (MS) detectors, provide multiples combinations for the quantitative and qualitative analysis at basal levels or higher concentrations of bioactive analytes in biological samples. Bearing this in mind, the development of food neuroprotective molecules as brain therapeutic agents is a complex task that requires the intimate collaboration and engagement of different disciplines for a successful outcome. In this sense, this work reviews the new advances achieved in the area toward a better understanding of the current state of the art and highlights promising approaches for brain neuroprotection

p38γ is essential for cell cycle progression and liver tumorigenesis

The cell cycle is a tightly regulated process that is controlled by the conserved cyclin-dependent kinase (CDK)–cyclin protein complex1. However, control of the G0-to-G1 transition is not completely understood. Here we demonstrate that p38 MAPK gamma (p38γ) acts as a CDK-like kinase and thus cooperates with CDKs, regulating entry into the cell cycle. p38γ shares high sequence homology, inhibition sensitivity and substrate specificity with CDK family members. In mouse hepatocytes, p38γ induces proliferation after partial hepatectomy by promoting the phosphorylation of retinoblastoma tumour suppressor protein at known CDK target residues. Lack of p38γ or treatment with the p38γ inhibitor pirfenidone protects against the chemically induced formation of liver tumours. Furthermore, biopsies of human hepatocellular carcinoma show high expression of p38γ, suggesting that p38γ could be a therapeutic target in the treatment of this disease

Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia

Clonal evolution in acute myeloid leukemia (AML) originates long before diagnosis and is a dynamic process that may affect survival. However, it remains uninvestigated during routine diagnostic workups. We hypothesized that the mutational status of bone marrow dysplastic cells and leukemic blasts, analyzed at the onset of AML using integrated multidimensional flow cytometry (MFC) immunophenotyping and fluorescence-activated cell sorting (FACS) with next-generation sequencing (NGS), could reconstruct leukemogenesis. Dysplastic cells were detected by MFC in 285 of 348 (82%) newly diagnosed patients with AML. Presence of dysplasia according to MFC and World Health Organization criteria had no prognostic value in older adults. NGS of dysplastic cells and blasts isolated at diagnosis identified 3 evolutionary patterns: stable (n = 12 of 21), branching (n = 4 of 21), and clonal evolution (n = 5 of 21). In patients achieving complete response (CR), integrated MFC and FACS with NGS showed persistent measurable residual disease (MRD) in phenotypically normal cell types, as well as the acquisition of genetic traits associated with treatment resistance. Furthermore, whole-exome sequencing of dysplastic and leukemic cells at diagnosis and of MRD uncovered different clonal involvement in dysplastic myelo-erythropoiesis, leukemic transformation, and chemoresistance. Altogether, we showed that it is possible to reconstruct leukemogenesis in ∼80% of patients with newly diagnosed AML, using techniques other than single-cell multiomics.This work was supported by grants from the Área de Oncología del Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red (CIBER-ONC) (CB16/12/00369, CB16/12/00233, CB16/12/00489, and CB16/12/00284), Instituto de Salud Carlos III/Subdirección General de Investigación Sanitaria (FIS numbers PI16/01661, PI16/00517, and PI19/01518), and the Plan de Investigación de la Universidad de Navarra (PIUNA 2014-18). This work was supported internationally by the Cancer Research UK, FCAECC, and AIRC under the Accelerator Award Program (EDITOR)

Role of NAFLD on the Health Related QoL Response to Lifestyle in Patients With Metabolic Syndrome: The PREDIMED Plus Cohort

ObjectiveTo evaluate the effect of Non-alcoholic fatty liver disease (NAFLD) status in the impact of lifestyle over Health-related quality of life (HRQoL) in patients with metabolic syndrome (MetS). MethodsBaseline and 1 year follow up data from the PREDIMED-plus cohort (men and women, 55-75 years old with overweight/obesity and MetS) were studied. Adherence to an energy-restricted Mediterranean Diet (er-MeDiet) and Physical Activity (PA) were assessed with a validated screeners. Hepatic steatosis index (HSI) was implemented to evaluate NAFLD while the SF-36 questionnaire provided HRQoL evaluation. Statistical analyses were performed to evaluate the influence of baseline NAFLD on HRQoL as affected by lifestyle during 1 year of follow up. ResultsData from 5205 patients with mean age of 65 years and a 48% of female participants. Adjusted linear multivariate mixed regression models showed that patients with lower probability of NAFLD (HSI < 36 points) were more responsive to er-MeDiet (beta 0.64 vs beta 0.05 per er-MeDiet adherence point, p< 0.01) and PA (beta 0.05 vs beta 0.01 per MET-h/week, p = 0.001) than those with high probability for NAFLD in terms Physical SF-36 summary in the 1 year follow up. 10 points of er-MeDiet adherence and 50 MET-h/week were thresholds for a beneficial effect of lifestyle on HRQoL physical domain in patients with lower probability of NAFLD. ConclusionThe evaluation of NAFLD by the HSI index in patients with MetS might identify subjects with different prospective sensitivity to lifestyle changes in terms of physical HRQoL (http://www.isrctn.com/ISRCTN89898870)

Treatment variability and its relationships to outcomes among patients with Wernicke's encephalopathy: A multicenter retrospective study

Background: Despite guidelines and recommendations, Wernicke's encephalopathy (WE) treatment lacks evidence, leading to clinical practice variability.Aims: Given the overall lack of information on thiamine use for WE treatment, we analyzed data from a large, well-characterized multicenter sample of patients with WE, examining thiamine dosages; factors associated with the use of different doses, frequencies, and routes; and the influence of differences in thiamine treatment on the outcome.Methods: This retrospective study was conducted with data from 443 patients from 21 centers obtained from a nationwide registry of the Spanish Society of Internal Medicine (from 2000 to 2012). Discharge codes and Caine criteria were applied for WE diagnosis, and treatment-related (thiamine dosage, frequency, and route of administration) demographic, clinical, and outcome variables were analyzed.Results: We found marked variability in WE treatment and a low rate of high-dose intravenous thiamine administration. Seventy-eight patients out of 373 (20.9%) received > 300 mg/day of thiamine as initial dose. Patients fulfilling the Caine criteria or presenting with the classic WE triad more frequently received parenteral treatment. Delayed diagnosis (after 24 h hospitalization), the fulfillment of more than two Caine criteria at diagnosis, mental status alterations, and folic acid deficiency were associated significantly with the lack of complete recovery. Malnutrition, reduced consciousness, folic acid deficiency, and the lack of timely thiamine treatment were risk factors for mortality.Conclusions: Our results clearly show extreme variability in thiamine dosages and routes used in the management of WE. Measures should be implemented to ensure adherence to current guidelines and to correct potential nutritional deficits in patients with alcohol use disorders or other risk factors for WE